Dr. Richard DRACHTMAN

Claim this profile

UMDNJ

Studies Sickle Cell Disease
Studies Sickle Cell Anemia
1 reported clinical trial
1 drug studied

Area of expertise

1Sickle Cell Disease
Richard DRACHTMAN has run 1 trial for Sickle Cell Disease. Some of their research focus areas include:
HbSS positive
HbSC positive
HbSβ0-thalassemia positive
2Sickle Cell Anemia
Richard DRACHTMAN has run 1 trial for Sickle Cell Anemia. Some of their research focus areas include:
HbSS positive
HbSC positive
HbSβ0-thalassemia positive

Affiliated Hospitals

Image of trial facility.
Novartis Investigative Site

Clinical Trials Richard DRACHTMAN is currently running

Image of trial facility.

Crizanlizumab

for Pediatric Sickle Cell Disease

The purpose of the Phase 2 CSEG101B2201 study is to confirm and to establish appropriate dosing and to evaluate the safety in pediatric participants ages 6 months to <18 years with a history of VOC with or without HU/HC, receiving crizanlizumab for 2 years. The efficacy and safety of crizanlizumab was already demonstrated in adults with sickle cell disease. The approach is to extrapolate from the PK/pharmacodynamics (PD) already established in the adult population. The study is designed as a Phase II, multicenter, open-label study.
Recruiting1 award Phase 2

More about Richard DRACHTMAN

Clinical Trial Related5 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Richard DRACHTMAN has experience with
  • Crizanlizumab
Breakdown of trials Richard DRACHTMAN has run
Sickle Cell Disease
Sickle Cell Anemia

Other Doctors you might be interested in

Jagadeesh GanjiMedication Management
Archna Bajaj, MDNovartis Investigative Site
Seth J. BaumExcel Medical Clinical Trials LLC

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Richard DRACHTMAN specialize in?
Richard DRACHTMAN focuses on Sickle Cell Disease and Sickle Cell Anemia. In particular, much of their work with Sickle Cell Disease has involved HbSS positive patients, or patients who are HbSC positive.
Is Richard DRACHTMAN currently recruiting for clinical trials?
Yes, Richard DRACHTMAN is currently recruiting for 1 clinical trial in New Brunswick New Jersey. If you're interested in participating, you should apply.
Are there any treatments that Richard DRACHTMAN has studied deeply?
Yes, Richard DRACHTMAN has studied treatments such as Crizanlizumab.
What is the best way to schedule an appointment with Richard DRACHTMAN?
Apply for one of the trials that Richard DRACHTMAN is conducting.
What is the office address of Richard DRACHTMAN?
The office of Richard DRACHTMAN is located at: UMDNJ, New Brunswick, New Jersey 08901 United States. This is the address for their practice at the UMDNJ.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top